Upgrade of an IFRS16 on-premise to an IFRS16 NL Cloud solution
KEYWORDS: IFRS16, NAKISA, SAP, CLOUD SOLUTION, PHARMACEUTICALS INDUSTRY
The Client
leading manufacturer of high-quality pharmaceuticals with headquarters in Germany and more than 12,520 employees around the globe. The company focuses on a three-pillar strategy of generics, specialty pharma, and nonprescription consumer healthcare products. Worldwide, its products are sold in approximately 120 countries.
Needing a trustful partner to support the upgrade of the IFRS16 on-premise solution into the IFRS16 cloud solution we helped our client to successfully transition and upgrade into a cloud solution by having a technical approach focused on SLAN (Nakisa on-premise), NLA (Nakisa on Cloud) and SAP.
The Challenge
Stada needed a trustful partner to support the upgrade of the IFRS16 on-premise solution into the IFRS16 cloud solution.
At the time, their main challenges included:
Contract Data migration
Testing of the new solution
Integration with SAP
First month-end closing in the new solution
For this project, our team showed and improved their technical expertise in:
Technical Approach
The Solution
Our team of experts supported the users in the UAT to make sure that complete and efficient testing was made, and they acted as an essential pillar in supporting some integration challenges between the new solution implemented and SAP.
Moreover, we carry out overlooking at the data migration process and validation of the first month-end closing.
Business Results
This project meant a successful transition and upgrade into a cloud solution having some of the key results:
Migration of 4000 contracts
Migration of 50 company codes
Successful go-live
Smooth process after the go-live by having a steadfast first month-end closing.
